Smith & Nephew plc acquires developer of unique pressure injury prevention device, Leaf Healthcare, Inc.

Smith & Nephew Plc

Smith & Nephew plc (LON:SN, NYSE:SNN), the global medical technology business, today announces that it has agreed to acquire Leaf Healthcare, Inc, the developer of the unique Leaf Patient Monitoring System for pressure injury prevention and patient mobility monitoring. The transaction follows Smith & Nephew’s successful two-year partnership with Leaf Healthcare as an exclusive distributor and strategic investor.

The Leaf Patient Monitoring System is comprised of a small, lightweight, wearable sensor that wirelessly monitors a patient’s position and their mobility whilst in a hospital. The tracking data is used to automate and document the compliance with prescribed turn protocols for patients at risk for pressure injuries.

An estimated 2.5 million pressure injuries are treated each year in US acute care facilities alone1, with an estimated annual burden of $11 billion in the United States2. National Pressure Ulcer Advisory Panel (NPUAP) guidelines recommend a prevention protocol for high-risk patients that includes prophylactic foam dressings, preventative skin care including pH balanced skin cleanser, and patient repositioning with early mobilisation3. The Leaf Patient Monitoring System together with Smith & Nephew’s ALLEVYN◊ LIFE and ALLEVYN GENTLE BORDER and SECURA◊ Skin Care products provide a comprehensive portfolio to help customers achieve and optimise pressure injury prevention protocols.

In January 2018, an independently conducted Randomized Controlled Trial (RCT) from Stanford University evaluated optimal patient repositioning and found that the Leaf Patient Monitoring System induced a 43% relative increase in turning protocol compliance in high-risk patients. Patients treated with the Leaf sensor were 73% less likely to develop a pressure injury4.

“Consistent with our initial strategic investment, Smith & Nephew is focused on providing not just products to treat conditions, but also supporting clinicians with technologies designed for prevention as well as treatment, and helping healthcare facilities reduce the cost of care,” said Simon Fraser,

President of Advanced Wound Management, Smith & Nephew. “The Leaf Patient Monitoring System is highly complementary to Smith & Nephew’s existing wound portfolio and we are excited by the opportunities of expanding this product within our global portfolio.”

“The benefits of patient turning and improved patient mobility are well recognised, including the potential for shorter hospital stays,” said Barrett Larson, MD, Co-Founder and Chief Executive Officer, Leaf Healthcare. “We are proud of the impact our technology has already made through our existing relationship with Smith & Nephew. We are excited by this new opportunity to deploy our award-winning pressure injury prevention technology through Smith & Nephew’s extensive Advanced Wound Management portfolio.”

The transaction is expected to close in Q2 2019, subject to the satisfaction of customary conditions, and will be financed from existing cash and debt facilities. The commercial terms have not been disclosed.

Share on:

Latest Company News

Smith & Nephew CFO John Rogers to step down in September

Smith & Nephew has announced John Rogers will leave as chief financial officer, with Pierre Palassian appointed interim CFO until a successor is named.

Smith & Nephew and Imperial College London open surgical robotics innovation centre

Smith & Nephew and Imperial College London have launched a five-year partnership to accelerate research and innovation in robotic surgery.

Smith & Nephew maintains profit guidance as H1 trading margin improves

Smith & Nephew reported higher half-year revenue, operating profit and cash generation, while reducing full-year revenue guidance.

Smith & Nephew reports steady Q1 growth and confirms 2026 outlook

Underlying revenue grew 3.1% in Q1, supported by innovation and strong Sports Medicine performance. The company maintains its full-year targets and unveils a new $500m buyback program.

Smith & Nephew to host Surgeon Insights event in London

Smith & Nephew will host an investor event in London featuring US surgeons discussing innovation platforms across sports medicine, wound care, and orthopaedics, with presentations and Q&A sessions led by company leadership.

Smith & Nephew delivers higher profits and cash generation in 2025

Smith+Nephew reported full-year 2025 revenue of $6.16 billion, up 6.1% on a reported basis, with trading profit rising 15.5% and free cash flow increasing 52.5%.

    Search